OPTIMIZERx Corporation (OTCBB: OPRX) announced today that it has moved from the OTC Pink Sheets listing and is now on the OTC Bulletin Board.

"Being cleared for the OTC Bulletin Board is a big step for OPTIMIZERx and its investors," said David Lester, CEO of OPTIMIZERx. "It will provide greater outside investment opportunity into OPTIMIZERx as we continue to develop and introduce new solutions to the marketplace."

OPTIMIZERx recently announced the introduction of SampleMD, a new solution for the distribution and administration of drug sampling and prescribed therapy persistency program at the Pharmaceutical Sampling conference in Philadelphia. "The conference validated that the industry is ready for a new approach at administrating and distributing branded samples," said David Harrell, Chairman of OPTIMIZERx and creator of SampleMD. "With fewer physicians no longer seeing drug reps, along with increasing compliance factors associated with distributing physical drug samples, pharmaceutical manufacturers are looking for new channels to the physicians and health care providers."

To learn more about SampleMD, visit http://beta.samplemd.com

Visit us online: www.optimizerx.com

Yahoo Finance: OPTIMIZERx Profile